Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Johnson and Johnson
Chubb
Boehringer Ingelheim
Express Scripts
McKinsey
Moodys
McKesson
Medtronic
AstraZeneca

Generated: October 16, 2017

DrugPatentWatch Database Preview

Isradipine - Generic Drug Details

« Back to Dashboard

What are the generic sources for isradipine and what is the scope of isradipine patent protection?

Isradipine
is the generic ingredient in three branded drugs marketed by Watson Labs Teva, Glaxosmithkline Llc, Smithkline Beecham, Mylan Pharms Inc, and Elite Labs Inc, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for isradipine. Five suppliers are listed for this compound.

Summary for Generic Name: isradipine

US Patents:0
Tradenames:3
Applicants:5
NDAs:5
Drug Master File Entries: see list7
Suppliers / Packagers: see list5
Bulk Api Vendors: see list57
Clinical Trials: see list8
Patent Applications: see list7,091
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:isradipine at DailyMed

Pharmacology for Ingredient: isradipine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline Llc
DYNACIRC CR
isradipine
TABLET, EXTENDED RELEASE;ORAL020336-002Jun 1, 1994DISCNYesNo► Subscribe► Subscribe► Subscribe
Watson Labs Teva
ISRADIPINE
isradipine
CAPSULE;ORAL077317-001Jan 5, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
Smithkline Beecham
DYNACIRC
isradipine
CAPSULE;ORAL019546-001Dec 20, 1990DISCNYesNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
ISRADIPINE
isradipine
TABLET, EXTENDED RELEASE;ORAL201067-002Nov 27, 2015RXNoNo► Subscribe► Subscribe► Subscribe
Elite Labs Inc
ISRADIPINE
isradipine
CAPSULE;ORAL077169-001Apr 24, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline Llc
DYNACIRC CR
isradipine
TABLET, EXTENDED RELEASE;ORAL020336-001Jun 1, 1994DISCNYesNo► Subscribe► Subscribe► Subscribe
Watson Labs Teva
ISRADIPINE
isradipine
CAPSULE;ORAL077317-002Jan 5, 2006ABRXNoYes► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
ISRADIPINE
isradipine
TABLET, EXTENDED RELEASE;ORAL201067-001Nov 27, 2015RXNoNo► Subscribe► Subscribe► Subscribe
Smithkline Beecham
DYNACIRC
isradipine
CAPSULE;ORAL019546-002Dec 20, 1990DISCNYesNo► Subscribe► Subscribe► Subscribe
Elite Labs Inc
ISRADIPINE
isradipine
CAPSULE;ORAL077169-002Apr 24, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: isradipine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline Llc
DYNACIRC CR
isradipine
TABLET, EXTENDED RELEASE;ORAL020336-001Jun 1, 1994► Subscribe► Subscribe
Smithkline Beecham
DYNACIRC
isradipine
CAPSULE;ORAL019546-001Dec 20, 1990► Subscribe► Subscribe
Glaxosmithkline Llc
DYNACIRC CR
isradipine
TABLET, EXTENDED RELEASE;ORAL020336-001Jun 1, 1994► Subscribe► Subscribe
Glaxosmithkline Llc
DYNACIRC CR
isradipine
TABLET, EXTENDED RELEASE;ORAL020336-002Jun 1, 1994► Subscribe► Subscribe
Smithkline Beecham
DYNACIRC
isradipine
CAPSULE;ORAL019546-002Dec 20, 1990► Subscribe► Subscribe
Glaxosmithkline Llc
DYNACIRC CR
isradipine
TABLET, EXTENDED RELEASE;ORAL020336-002Jun 1, 1994► Subscribe► Subscribe
Glaxosmithkline Llc
DYNACIRC CR
isradipine
TABLET, EXTENDED RELEASE;ORAL020336-001Jun 1, 1994► Subscribe► Subscribe
Glaxosmithkline Llc
DYNACIRC CR
isradipine
TABLET, EXTENDED RELEASE;ORAL020336-002Jun 1, 1994► Subscribe► Subscribe
Glaxosmithkline Llc
DYNACIRC CR
isradipine
TABLET, EXTENDED RELEASE;ORAL020336-001Jun 1, 1994► Subscribe► Subscribe
Glaxosmithkline Llc
DYNACIRC CR
isradipine
TABLET, EXTENDED RELEASE;ORAL020336-001Jun 1, 1994► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Chinese Patent Office
Dow
Colorcon
Citi
Teva
Express Scripts
Queensland Health
Harvard Business School
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot